Schroder Investment Management Group
KZR

Schroder Investment Management Group’s Kezar Life Sciences KZR Stock Holding History

Schroder Investment Management Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,039
Closed -$210K – 1236
2024
Q2 		$210K Hold
35,039
– – ﹤0.01% 1166
2024
Q1 		$316K Hold
35,039
– – ﹤0.01% 1143
2023
Q4 		$332K Buy
+35,039
New +$308K ﹤0.01% 1118
2023
Q1 		– Sell
-43,520
Closed -$3.06M – 1292
2022
Q4 		$3.06M Buy
43,520
+1,546
+4% +$115K ﹤0.01% 872
2022
Q3 		$3.61M Buy
41,974
+16,420
+64% +$1.6M 0.01% 838
2022
Q2 		$2.03M Hold
25,554
– – ﹤0.01% 962
2022
Q1 		$4.32M Buy
+25,554
New +$3.67M 0.01% 877

Other funds holding KZR

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Schroder Investment Management Group's KZR Position: Q3 2024 in Review

Schroder Investment Management Group sold out of Kezar Life Sciences (KZR) in Q3 2024, closing a stake of 35,039 shares — an estimated $210K sold.

Schroder Investment Management Group first reported a position in KZR in Q1 2022 and held it in 7 quarters. The position peaked at $4.32M in Q1 2022. 59 funds tracked by Wall St. Rank hold KZR as of Q3 2024.

  • Schroder Investment Management Group reported no remaining Kezar Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Schroder Investment Management Group sold 35,039 Kezar Life Sciences shares in Q3 2024, an estimated $210K.
  • Schroder Investment Management Group first reported a position in Kezar Life Sciences in Q1 2022 and held it in 7 quarters.
  • Schroder Investment Management Group's Kezar Life Sciences position peaked at $4.32M in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2024.

Based on Schroder Investment Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.